ASX Share rice
Sun 09 May 2021 - 05:42:pm (Sydney)

IHL Share Price

IMPRESSION HEALTHCARE LIMITEDIHLHealth Care Equipment & Services

IHL Company Information

Name:

Incannex Healthcare Limited

Sector:

Healthcare

Industry:

Drug Manufacturers-Specialty & Generic

GIC Industry:

Health Care Equipment & Supplies

GIC Sub Industry:

Health Care Supplies

Address:

Rialto South Tower Melbourne VIC Australia 3000

Phone:

61 4 2570 3805

MD, CEO & Exec. Director:

Mr. Joel Bradley Latham

Chairman of Medical Advisory Board, Chief Medical Officer & Non-Exec. Director:

Dr. Sud Agarwal B.Sc.

Chief Exec. Officer of IncannexTM:

Mr. John Michailidis B.Sc., EMBA, M.A.I.C.D.

Company Sec.:

Mr. Glenn Fowles BBS

Company Overview:

Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's therapeutic products in clinical trials include IHL-42X for obstructive sleep apnea; IHL-216A for traumatic brain injury; IHL-675A for sepsis associated acute respiratory distress syndrome; and IHL-493C for temporomandibular joint dysfunction. It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea. Incannex Healthcare Limited has a partnership with Monash Trauma Group at the Department of Neuroscience, Monash University to conduct an in vivo study on the protective effect of IHL-216A in sports concussion. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited is based in Melbourne, Australia.

IHL Share Price Information

Shares Issued:

1.06B

Market Capitalisation:

$322.96M

Revenue (TTM):

$1.78M

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.006

Operating Margin (TTM):

$-2.63

Return On Assets (TTM):

$-0.33

Return On Equity (TTM):

$-0.58

Quarterly Revenue Growth (YOY):

159.158

Gross Profit(TTM):

$159.08K

Diluted Earnings Per Share (TTM):

$-0.007

IHL CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$13K

Change To Liabilities:

$464.22K

Total Cashflow From Investing Activities:

$13K

Net Borrowings:

$-65,000

Net Income:

$-4,697,636

Total Cash From Operating Activities:

$-3,907,334

Depreciation:

$36.54K

Other Cashflow From Investing Activities:

$13K

Change To Inventory:

$-30,355

Change To Account Receivables:

$-315,484

Sale Purchase Of Stock:

$7.47M

Capital Expenditures:

$0

IHL Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-3,929,280

Net Income:

$-4,697,640

Gross Profit:

$154.54K

Operating Income:

$-3,929,290

Other Operating Expenses:

$-212,625

Total Revenue:

$822.05K

Cost Of Revenue:

$450.35K

IHL Balance Sheet

Balance Sheet Date:

2020-06-30

Total Liabilities:

$1.07M

Total Stockholder Equity:

$3.16M

Other Current Liabilities:

$116.65K

Total Assets:

$4.24M

Common Stock:

$34.19M

Other Current Assets:

$25.18K

Retained Earnings:

$-32,518,203

Cash:

$3.60M

Total Current Liabilities:

$1.07M

Net Tangible Assets:

$3.16M

Total Current Assets:

$4.24M

Net Receivables:

$413.27K

Short-Term Investments:

$0

Inventory:

$183.16K

Accounts Payable:

$590.10K

Short-Term Investments:

$0

Non Current Liabilities Total:

$0

IHL Share Price History

IHL News

01 Mar, 2021
The Incannex Healthcare Limited ( ASX:IHL ) share price has had a bad week, falling 10%. But that doesn't change the...
01 Dec, 2020
Joel Latham became the CEO of Incannex Healthcare Limited (ASX:IHL) in 2018, and we think it's a good time to look at...